Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ipsen's Enterprise Value is $14,604 Mil.
Ipsen's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $722 Mil. Therefore, Ipsen's EV-to-EBIT ratio for today is 20.24.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ipsen's Enterprise Value is $14,604 Mil.
Ipsen's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $1,450 Mil. Therefore, Ipsen's EV-to-EBITDA ratio for today is 10.07.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ipsen's Enterprise Value is $14,604 Mil.
Ipsen's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $4,567 Mil. Therefore, Ipsen's EV-to-Revenue ratio for today is 3.20.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Ipsen's Enterprise Value is $14,604 Mil.
Ipsen's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $942 Mil. Therefore, Ipsen's EV-to-FCF ratio for today is 15.50.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Ipsen (OTCPK:IPSEF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ipsen's current Enterprise Value is $14,604 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ipsen's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $722 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ipsen's current Enterprise Value is $14,604 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ipsen's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $1,450 Mil.
Ipsen's current Enterprise Value is $14,604 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ipsen's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $4,567 Mil.
Ipsen's current Enterprise Value is $14,604 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ipsen's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $1,324 Mil.
Ipsen's current Enterprise Value is $14,604 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ipsen's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $942 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipsen Enterprise Value Related Terms
Ipsen Enterprise Value Historical Data
* Premium members only.
The historical data trend for Ipsen's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPSEF vs ZTS, UTHR, VTRS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ipsen Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ipsen's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ipsen's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ipsen's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipsen (IPSEF) has a Enterprise Value of $14,604 Mil as of Jun. 24, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ipsen and its competitors.
Is Ipsen's Enterprise Value too high?
Ipsen's current Enterprise Value is $14,604 Mil. Overall, Ipsen has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Ipsen's Enterprise Value compare to ZTS and UTHR?
Ipsen's Enterprise Value of $14,604 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ipsen and its competitors. Ipsen's current Enterprise Value is $14,604 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipsen stock overvalued right now?
Ipsen (IPSEF) has a current Enterprise Value of $14,604 Mil. The stock's GF Value™ is $92.81, compared to a current price of $113.13 — trading 21.9% above its estimated fair value. The current Enterprise Value is $14,604 Mil. Ipsen's overall GF Score™ is 95/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Ipsen (IPSEF), the current Enterprise Value is $14,604 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ipsen (IPSEF) Overvalued in 2026?
Based on GuruFocus' analysis, Ipsen stock appears to be overvalued.
The current stock price of $113.13 is trading 21.9% above its estimated GF Value™ of $92.81.
Key valuation signals for IPSEF:
Enterprise Value: $14,604 Mil
GF Value™: $92.81 vs. price of $113.13 (21.9% above fair value)
No single metric tells the full story. See the IPSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
95GF Score
Get the complete analysis for IPSEF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IPSEF has been successfully added to your 
